Omni Health Inc (OMHE)

[lesgetrich]

VTCQ USA and MCIG USA won't benefit from any overseas VitaStik sales until their old contracts expire 3-5 years from the date of the original contract.

The fantasy continues. As I've been saying, the prior contract never went into effect because it was impossible to ship the product to Korea. As I've said repeatedly in the past...

...any prior contract with Korea was rendered null and void when Korean customs refused entry of Vitastiks into the country because they couldn't be classified as e-cigarettes due to a lack of any nicotine. Since then, Korea has been ordering components directly from the Chinese manufacturer and assembling the product in Korea. The new US asian trade agreement may have resolved this issue. In any event, this complicates the negotiations. There are also questions about whether Korea and other asian nations allow sale of CBD products. Once these issues are resolved there will be a new contract with the Korean partner.

From today's PR...

VitaCig Renews South Korea Partnership, Expands Distribution Into Japan

We are excited to announce that we have renewed our partnership with our Korean Partner Kooleever, Inc. For the past six months, our partnership was put on hold while Kooleever addressed governmental regulatory and customs issues concerning, non-nicotine e-cigs. Having overcome these hurdles, both parties have now renewed their agreement, and subsequently, Kooleever has placed their first order of 2016 with VitaCig.

Also, if you read the entire previous PR in context there is no way to come to the conclusion that VitaStiks aren't covered.

Following several months of negotiations, VitaCig U.S., and EU Vitastik Partner, has reached an historic agreement that will entitle VitaCig U.S., to significant royalty payments of up to 25% of all product sales. This agreement will include territories and partners throughout Europe, including UK, Austria, Switzerland, Spain, Italy, covering a population of 745 million people. Spear headed, and managed by Vitastik EU CEO, Johannes Luis. According to this agreement, all product orders from Vitastik EU and their partners will go through a special EU VitaCig account. The term of this agreement runs effective January 1st 2016 - December 21st 2019. Thereafter, the agreement shall be renewed for an additional one-year-term, upon consent of both parties.

In addition to royalty payments, Vitastik EU will also take an active role in supporting our highly anticipated VitaCig product line relaunch, expected by March 1st, for the U.S. market. Not limited to, a fully mobile responsive, website design, a T.V. commercial, SEO, and Google analytics. This will well position us to experience unprecedented sales growth for 2016 and beyond.

VitaStik EU CEO Johannes Luis Schmid comments, "This strategic partnering agreement between US and EU is a huge milestone for both companies. There is strength in numbers. Our goal together, is to unite the brand, and build an empire. Dominate the disposable e-cig space. My team and I have built a solid foundation in 2015. We continue to experience record revenue growth monthly. Our re-order rate of 45%, is at an all-time high. We project to record $3.5m - $4m in revenues by year end. I look forward to contribute what has been working for us, and infuse into the U.S. market. I look forward to many years working together."

VitaCig CEO Paul Rosenberg adds, "This royalty agreement demonstrates the dynamism and value of our VitaCig brand. There is truly no other product like it on the market, and continues to see tremendous success abroad. The EU Partner agreement is part of a comprehensive effort by the company to lock-in international distribution and royalty agreements. Our vision and strategy for VitaCig is simple and clear. Dominate both the e-cig disposable, and CBD markets, on a global scale.

It's clear that the contract includes e-cigarettes as well as CBD products